• Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • NSCLC
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • Type I Diabetes
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

Study shows consumer-directed health plans find their niche

Article

The number of enrollees in consumer-directed health plans (CDHPs) could reach 15 million by 2010 and 30 million by 2015, according to a study by The Zitter Group. The question that the study couldn't answer is whether employers might eventually mandate CDHPs for their employees as a way to control healthcare costs.

SAN FRANCISCO-The number of enrollees in consumer-directed health plans (CDHPs) could reach 15 million by 2010 and 30 million by 2015, according to a study by The Zitter Group. The question that the study couldn't answer is whether employers might eventually mandate CDHPs for their employees as a way to control healthcare costs.

Currently, there is no trend toward mandatory CDHPs, but it could happen in the foreseeable future as costs continue to rise, says John Sheehan, an associate of strategy and analytics for The Zitter Group and the study's lead investigator.

As long as CDHPs are just an option, their effect on healthcare costs appears limited, he says, because they primarily attract members who use the fewest healthcare resources. Patients with chronic illnesses would opt to remain in their present plans rather than switching to CDHPs, which discourage healthcare spending.

The consensus among plan decision-makers is that CDHPs fill a niche, primarily for educated, wealthy professionals capable of taking advantage of the tax benefits and lower premiums, the study says. The study revealed other findings.

"Despite the savings potential for enrollees and employers, these plans can result in disaster when coverage is needed because of an emergency or chronic illness," Sheehan says. "What safeguards will ensure that enrollees are getting the care they need and not falling prey to inherent disincentives created by CDHPs?"

Related Videos
Video 2 - "Identifying Inequities in CGM Access"
Video 1 - "Challenges in Treating High-Risk Patients With Diabetes"
Video 17 - "Insights on Plan Enhancements & Fertility Care Innovations"
Video 16 - "Mitigating Risks: How Fertility Benefits Safeguard Employee Health"
Video 15 - "Strategic Investment: Fertility Benefits and Positive Employee Outcomes"
"Supporting Employee Wellbeing Through Fertility Benefits"
Video 13 - "Reshaping Perspective on Fertility Care Coverage"
Video - "Enhancements and Innovations in Fertility Care"
Video 11 - "Closing Current Gaps within Fertility Benefits and Care"
Video 10 - "Shaping Fertility Coverage: Access, Costs & Medical Needs"
Related Content
© 2024 MJH Life Sciences

All rights reserved.